This morning CVS announced a plan to eliminate the out of pocket cost for branded diabetes medications. Per a company issued press release;
“CVS Health (NYSE: CVS) today announced a new solution eliminating member out-of-pocket costs associated with all diabetes prescription medications, including insulin.”
CVS noted that patients on average spend $467.24 per year out of pocket with 12% of their patient population spending over $1,000 per year. CVS is just the latest company to offer a program making diabetes medications more affordable. Lilly and Novo Nordisk have also launched programs to lower the . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.